Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (51-60 of 264) with videos related to

Pageof 27
Sort By:
Annals of Hematology|April 15, 2004
Concomitant occurrence of MALT lymphoma and multiple myelomaStefan Wöhrer, Markus Raderer, Berthold Streubel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjögren's syndromeBerthold Streubel, Daniela Huber, Stefan Wöhrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Reverse transcription-PCR for t(11;18)(q21;q21) staging and monitoring in mucosa-associated lymphoid tissue lymphomaBerthold Streubel, Daniela Huber, Stefan Wöhrer, et al.
Leukemia & Lymphoma|August 20, 2005
Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomideMathias Kees, Markus Raderer, Sylvia Metz-Schimmerl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2025
Comparisons of treatment performance and therapy sequences in neuroendocrine neoplasms using progression-free survival ratiosPhilipp Melhorn, Elisabeth Kretschmer-Chott, Peter Mazal, et al.
The British Journal of Radiology|July 25, 2018
DWI-MRI <i>vs</i> CT in gastric MALT lymphoma-preliminary results in 19 patientsDominik Berzaczy, Anton Staudenherz, Markus Raderer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 24, 2024
Long-term experience with octreotide and lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumorsBarbara Kiesewetter, Friedrich Franz Pflüger, Philipp Melhorn, et al.
Annals of Hematology|April 3, 2004
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenumMartha Hoffmann, Andreas Chott, Andreas Püspök, et al.
Case Reports in Oncology|May 29, 2018
Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the DuodenumBarbara Kiesewetter, Werner Dolak, Marius E Mayerhoefer, et al.
Cancers|February 26, 2020
Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) LymphomaBarbara Kiesewetter, Ingrid Simonitsch-Klupp, Werner Dolak, et al.
Pageof 27

Showing results (51-60 of 264) with videos related to

Sort By:
Pageof 27
Annals of Hematology|April 15, 2004
Concomitant occurrence of MALT lymphoma and multiple myelomaStefan Wöhrer, Markus Raderer, Berthold Streubel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjögren's syndromeBerthold Streubel, Daniela Huber, Stefan Wöhrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Reverse transcription-PCR for t(11;18)(q21;q21) staging and monitoring in mucosa-associated lymphoid tissue lymphomaBerthold Streubel, Daniela Huber, Stefan Wöhrer, et al.
Leukemia & Lymphoma|August 20, 2005
Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomideMathias Kees, Markus Raderer, Sylvia Metz-Schimmerl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2025
Comparisons of treatment performance and therapy sequences in neuroendocrine neoplasms using progression-free survival ratiosPhilipp Melhorn, Elisabeth Kretschmer-Chott, Peter Mazal, et al.
The British Journal of Radiology|July 25, 2018
DWI-MRI <i>vs</i> CT in gastric MALT lymphoma-preliminary results in 19 patientsDominik Berzaczy, Anton Staudenherz, Markus Raderer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 24, 2024
Long-term experience with octreotide and lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumorsBarbara Kiesewetter, Friedrich Franz Pflüger, Philipp Melhorn, et al.
Annals of Hematology|April 3, 2004
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenumMartha Hoffmann, Andreas Chott, Andreas Püspök, et al.
Case Reports in Oncology|May 29, 2018
Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the DuodenumBarbara Kiesewetter, Werner Dolak, Marius E Mayerhoefer, et al.
Cancers|February 26, 2020
Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) LymphomaBarbara Kiesewetter, Ingrid Simonitsch-Klupp, Werner Dolak, et al.
Pageof 27